Tetra Radar · Company Timeline

Corcept Therapeutics Incorporated (CORT)

Sector: Health Care

Earlier observations

  1. · FDA approval. The FDA approved LIFYORLI (COPACKAGED) to treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least one of which included bevacizumab.

Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.

Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.